Literature DB >> 16763796

[Clinical pathway "Acute Coronary Syndrome"].

W Grimm1, B Maisch.   

Abstract

The clinical pathway "acute coronary syndrome" of the university hospital Marburg describes the guideline-conform and consented management of patients with ST-segment elevation infarct (STEMI), non-ST-segment elevation infarct (NSTEMI) and Troponin negative unstable angina. A 12-lead ECG recording is made and read in all patients within 10 minutes. All patients with STEMI undergo immediate revascularisation using primary percutanuous catheter intervention (PCI) after administration of basic medical therapy. Primary PCI is also used in all patients with NSTEMI, persistent chest pain, rhythm or hemodynamic instability. Patients with unstable angina, who became free of symptoms after application of basic medication, but who have additional risk factors undergo cardiac catheterisation within 48 hours. Acute myocardial infarction can be ruled out in patients with twofold negative cardiac troponin levels during 6-12 hours. In the absence of further symptoms, these patiens undergo differential diagnostic evaluation of cardiac and extracardiac causes of chest pain. The introduction of this clinical pathway 2 years ago, which was consented before by the hospital board and the clinical directors, has lead to a remarkable improvement in the clinical decision-making at the emergency room of the hospital and reduced the door to intervention time considerably.

Entities:  

Mesh:

Year:  2006        PMID: 16763796     DOI: 10.1007/s00108-006-1644-5

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  21 in total

1.  [Guidelines: acute coronary syndrome (ACS). 1: ACS without persistent ST segment elevations].

Authors:  C W Hamm
Journal:  Z Kardiol       Date:  2004-01

2.  A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS).

Authors:  D Hasdai; S Behar; L Wallentin; N Danchin; A K Gitt; E Boersma; P M Fioretti; M L Simoons; A Battler
Journal:  Eur Heart J       Date:  2002-08       Impact factor: 29.983

3.  5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial.

Authors:  K A A Fox; P Poole-Wilson; T C Clayton; R A Henderson; T R D Shaw; D J Wheatley; R Knight; S J Pocock
Journal:  Lancet       Date:  2005 Sep 10-16       Impact factor: 79.321

Review 4.  [Prehospital accommodation of patients with acute coronary syndrome. Summary position paper of the German Society for Cardiological, Heart and Circulatory Research e.V. and the German Interdisciplinary Coalition for Intensive and Emergency Medicine].

Authors:  H R Arntz
Journal:  Z Kardiol       Date:  2004-11

5.  Influence of timing of troponin elevation on clinical outcomes and use of evidence-based therapies for patients with non-ST-segment elevation acute coronary syndromes.

Authors:  Matthew T Roe; Eric D Peterson; Charles V Pollack; L Kristin Newby; Yun Li; Robert H Christenson; W Frank Peacock; Francis M Fesmire; Deborah Diercks; J Douglas Kirk; Sidney C Smith; E Magnus Ohman; W Brian Gibler
Journal:  Ann Emerg Med       Date:  2005-04       Impact factor: 5.721

6.  Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE).

Authors:  K A A Fox; S G Goodman; W Klein; D Brieger; P G Steg; O Dabbous; A Avezum
Journal:  Eur Heart J       Date:  2002-08       Impact factor: 29.983

7.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction).

Authors:  Elliott M Antman; Daniel T Anbe; Paul Wayne Armstrong; Eric R Bates; Lee A Green; Mary Hand; Judith S Hochman; Harlan M Krumholz; Frederick G Kushner; Gervasio A Lamas; Charles J Mullany; Joseph P Ornato; David L Pearle; Michael A Sloan; Sidney C Smith; Joseph S Alpert; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Gabriel Gregoratos; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs
Journal:  Circulation       Date:  2004-08-31       Impact factor: 29.690

8.  Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes.

Authors:  E M Antman; M J Tanasijevic; B Thompson; M Schactman; C H McCabe; C P Cannon; G A Fischer; A Y Fung; C Thompson; D Wybenga; E Braunwald
Journal:  N Engl J Med       Date:  1996-10-31       Impact factor: 91.245

Review 9.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

10.  Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology.

Authors:  Sigmund Silber; Per Albertsson; Francisco F Avilés; Paolo G Camici; Antonio Colombo; Christian Hamm; Erik Jørgensen; Jean Marco; Jan-Erik Nordrehaug; Witold Ruzyllo; Philip Urban; Gregg W Stone; William Wijns
Journal:  Eur Heart J       Date:  2005-03-15       Impact factor: 29.983

View more
  1 in total

Review 1.  [Myocardial infarct and unstable angina pectoris: diagnostics and therapy].

Authors:  M Weber; C Hamm
Journal:  Internist (Berl)       Date:  2007-04       Impact factor: 0.743

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.